CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 372 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00833638
NCT00833638Phase 4Completed
CompareCT.gov

Tadalafil 2.5 mg and 5 mg Once a Day Compared to Placebo in Day of Onset of Efficacy

Eli Lilly and Company·interventional·Posted Feb 2, 2009·Updated Aug 24, 2010

In Brief

A Phase 4 clinical trial evaluating Placebo and Tadalafil for Erectile Dysfunction. Completed, enrolled 372 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the day of onset of efficacy of tadalafil dosed once-a-day.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2, 2009
Enrollment StartFeb 1, 2009
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.4 years ago

Interventions

Placebodrug

One tablet orally daily

Tadalafildrug

Orally once daily